Back
Protagonist Therapeutics, Inc. Vs. Enanta Pharmaceuticals, Inc. Industry Stock Comparison
Sell
39
PTGX
Protagonist Therapeutics, Inc.
Last Price:
$87.86
Seasonality Move:
15.02%
Sell
42
ENTA
Enanta Pharmaceuticals, Inc.
Last Price:
$16.44
Seasonality Move:
10.84%
Sell
39
Protagonist Therapeutics, Inc. (PTGX)
is a Sell
Is Protagonist Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Protagonist Therapeutics, Inc. [PTGX] share price is $88.78. The Score for PTGX is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
PTGX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Enanta Pharmaceuticals, Inc. (ENTA)
is a Sell
Is Enanta Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Enanta Pharmaceuticals, Inc. [ENTA] share price is $16.85. The Score for ENTA is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
ENTA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PTGX Stock Price Chart
What is Protagonist Therapeutics, Inc.'s stock price today?
-
The Protagonist Therapeutics, Inc. share price today is $88.78Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTGX is experiencing slight buying pressure.
ENTA Stock Price Chart
What is Enanta Pharmaceuticals, Inc.'s stock price today?
-
The Enanta Pharmaceuticals, Inc. share price today is $16.85Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ENTA is experiencing buying pressure, which is a positive indicator for future bullish movement.
PTGX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 24.08 | Buy |
| Relative Strength Index (14 RSI): | 53.49 | Buy |
| Chaikin Money Flow: | 87500 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (85.94 - 91.62) | Sell |
| Bollinger Bands (100): | (59.69 - 85.71) | Buy |
ENTA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.97 | Buy |
| Relative Strength Index (14 RSI): | 72.39 | Buy |
| Chaikin Money Flow: | 215444 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.25 - 15.47) | Buy |
| Bollinger Bands (100): | (8.19 - 13.45) | Buy |
PTGX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 88.31 | Buy |
| 20-day SMA: | 89.12 | Sell |
| 50-day SMA: | 83.99 | Buy |
| 200-day SMA: | 61.33 | Buy |
| 8-day EMA: | 72.97 | Buy |
| 20-day EMA: | 44.31 | Buy |
| 50-day EMA: | 21.47 | Buy |
| 200-day EMA: | 5.94 | Buy |
ENTA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.44 | Buy |
| 20-day SMA: | 14.74 | Buy |
| 50-day SMA: | 12.78 | Buy |
| 200-day SMA: | 8.6 | Buy |
| 8-day EMA: | 15.7 | Buy |
| 20-day EMA: | 14.73 | Buy |
| 50-day EMA: | 13.13 | Buy |
| 200-day EMA: | 10.14 | Buy |
Protagonist Therapeutics, Inc. Earnings Growth & PTGX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $1.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $4.50 per share, and an increase next year of $2.93 per share.
Enanta Pharmaceuticals, Inc. Earnings Growth & ENTA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.40 per share, and an increase next year of $0.71 per share.
Protagonist Therapeutics, Inc. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Enanta Pharmaceuticals, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||